Trusted Press Release Distribution   Plans | Login    

Briefing Search
Keyword:
Category:

       

    
Author Details
IndustryARC
www.industryarc.com/
Venkat Reddy
venkat@industryarc.com
(+1) 970-236-3677

Bookmark and Share
Antibodies Market Size Forecast to Reach $247.8 Billion by 2026
Growing Demand for Personalized Medicine and Structure Based Drug Design Along With the Increasing Demand for Therapeutic Antibodies Is Set To Further Enhance the Overall Market Development of the Antibodies Market

BriefingWire.com, 10/11/2021 - [FURL=https://www.industryarc.com/Research/Antibodies-Market-Research-508407?utm_source=freeprnow&utm_medium=pressrelease&utm_campaign=paidpressrelease]Antibodies Market[/FURL] Antibodies Market size is forecast to reach $247.8 billion by 2026, growing at a CAGR of 12.3% during the forecast period 2021-2026. Antibodies are produced in response to antigens by plasma cells. It is also known as immunoglobin and are used as diagnostics as well as therapeutics purposes for various indications of diseases such as macular degeneration, crohn’s disease, psoriasis, and asthma among others. Antibodies are made by B cells and have the ability to bind themselves to specific molecules. It is also used to aid in the identification of molecules. They are capable of identifying unique molecules that have harmful agents.

Key Takeaways

North America dominated the Antibodies Market in 2020 owing to the development of structure based drug designs and increasing research in the fields of proteomics as well as in genomics. The Antibodies Market scope for different regions will be provided in the final report.

Increasing prevalence of chronic disease and increasing applications in oncology, neurobiology, cardiology, and autoimmunology are likely to aid the market growth of the Antibodies Market report.

Detailed analysis of the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Antibodies Market report.

High cost of therapeutic antibodies and quality concerns along with the lack of reproducible results is poised to create the hurdles for the Antibodies Market.

Download Sample Report @ [FURL]https://www.industryarc.com/pdfdownload.php?id=508407[/FURL]

Antibodies Market Segment Analysis – By Geography

North America dominated the Antibodies Market with a major share of 39.7% in 2020. This is attributed to the growing research in the fields of proteomics & genomics, and presence of key players of biopharmaceuticals & biotechnology firms. Increasing prevalence of cardiovascular disease, increasing demand for antibodies for research reproductivity, government investments in improving healthcare expenditures, and increasing development activities to develop effective diagnostic therapy is increasing the growth of the market in this region. However, Asia Pacific is estimated to grow at a higher CAGR during the forecast period 2021-2026 owing to the increasing number of research activities, improving healthcare infrastructure, and increasing pharmaceuticals investments.

Antibodies Market Drivers

Availability of Inexpensive Biosimilar Therapeutic Antibodies

Growing Prevalence of Various Forms of Autoimmune Disorders

Antibodies Market Landscape

The Antibodies Market, top 10 companies are Abbott Diagnostics, AG Scientific Inc, Bristol Myers Squibb, Novartis AG, Pfizer Inc., and Thermo Fisher Scientific Inc. among others.

About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.

 
 
FAQs | Contact Us | Terms & Conditions | Privacy Policy
© 2024 Proserve Technology, Inc.